PARISA KHAJUEE: Open Payments
NPI 1952648842 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 94 payments from 12 companies in 2025. Trend: 2023 $150 · 2024 $3,354 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 38 | $542 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $265 |
| PFIZER INC. | 13 | $254 |
| Lilly USA, LLC | 10 | $174 |
| Vanda Pharmaceuticals Inc. | 9 | $159 |
| Teva Pharmaceuticals USA, Inc. | 6 | $141 |
| Alkermes, Inc. | 2 | $53 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Grifols USA, LLC | 1 | $18 |
Products named: REXULTI, CAPLYTA, NURTEC ODT, AUSTEDO XR, HETLIOZ, AMYVID, KISUNLA, ARISTADA.
Industry payments across NY — which companies pay providers there.
